Deirdre Dunn Tierney

The committee held a meeting covering various administrative and program updates. Discussions included membership appointments, including the designation of the Chair and Vice Chair, and the transition of the Beneficiary Advisory Committee. The group discussed future agenda topics such as workforce support, Medicaid impacts, and home health services. The Department provided updates on legislative affairs, including federal work requirements, and the Rural Health Transformation Program. Additionally, the committee received an annual post-award forum presentation concerning the 1115 demonstration waiver, which covers substance use disorder treatment, serious mental illness programs, dental benefits, and community reentry services for incarcerated individuals.

The committee held an executive meeting to address several confidential agenda topics. The meeting transitioned into a non-public session to discuss committee membership, case selection regarding poisoning cases scheduled for July, committee surveys, and an annual report recap alongside an HHS oversight committee update. Following these discussions, the meeting returned to public session, where it was confirmed that no other business was brought forward.

The meeting focused on the transition to a quarterly meeting cadence for the Medical Advisory Committee. Participants discussed strategies for managing rulemaking during intervening months, including the potential to hold optional monthly meetings to ensure meaningful engagement and timely subcommittee reporting. Concerns were addressed regarding subcommittee communication processes and the need for a collaborative approach to presenting recommendations for full committee approval. Technical logistics for hybrid meeting setups were also briefly noted.

The Advisory Council discussed strategies for ensuring a quorum at meetings, including the requirement for virtual participants to keep their video on. The meeting included discussions on the legislative review process, with efforts to track and narrow down legislation relevant to health improvement plan domains. Participants explored the potential for creating a repository for bill review information and discussed the balance between proactive and reactive engagement in the legislative process. Additionally, plans for an upcoming in-person meeting were announced.

The meeting agenda includes comments from the Chair and updates from the Commissioner and Director, with a review of a dashboard. Additionally, the commission will cover updates from the Opioid Abatement Commission, a legislative update from Senator Watters, and reports from the Budget, Coordination and Cooperation, and Data task forces.